---

Evangelos Gragoudas

Director, Retina Services, Massachusetts Eye and Ear, Boston, Massachusetts

A world authority on the diagnosis and management of intraocular tumors, Evangelos Gragoudas pioneered the use of proton beam irradiation therapy in the treatment of uveal melanoma. Along with Joan Miller and Anthony Adamis, Gragoudas was one of the first to describe the role of VEGF in pathologic retinal neovascularization. With a long-standing interest in retinal disorders, Gragoudas helped identify vascular-targeting therapies for neovascular diseases of the eye, and he was instrumental in developing photodynamic therapy using verteporfin, which became the first FDA-approved treatment for AMD. 

---

Part of the Power List 2016

100 reasons to be proud

Welcome to The Power List 2016 – our second foray into the Top 100 most influential people in the world of ophthalmology.

Though we realize our list can (and should) never be definitive, who can argue that the faces within – both familiar and new – do not beautifully highlight the brilliance and diversity found within the field?

Here, we celebrate 100 reasons to be proud of ophthalmology.

Go to The Power List 2016